Solvay sells drugs unit to Abbott for $6.6 billion

AMSTERDAM (Reuters) – Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.

Leave a Reply